690. Activity of a Novel Polymyxin Analog, QPX9003, Tested Against Resistant Gram-Negative Pathogens, Including Carbapenem-Resistant Acinetobacter, Enterobacterales, and Pseudomonas

BACKGROUND: Multidrug resistance (MDR) among Gram-negative (GN) organisms and the limited active therapeutic options against these pathogens are matters of worldwide concern. Polymyxins are cationic peptides that act on the bacterial cell membrane and have good activity against GN organisms, includi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Castanheira, Mariana, Lindley, Jill, Huynh, Holly, Mendes, Rodrigo E, Lomovskaya, Olga
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811097/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.758
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires